nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—PTGS1—Naproxen—gout	0.0942	0.151	CbGbCtD
Bortezomib—PTGS1—Indomethacin—gout	0.0622	0.0998	CbGbCtD
Bortezomib—CYP2C8—Naproxen—gout	0.0544	0.0871	CbGbCtD
Bortezomib—CYP1A2—Naproxen—gout	0.0421	0.0674	CbGbCtD
Bortezomib—CYP2C8—Colchicine—gout	0.0412	0.066	CbGbCtD
Bortezomib—CYP2C9—Naproxen—gout	0.0379	0.0608	CbGbCtD
Bortezomib—CYP2C8—Probenecid—gout	0.0369	0.0591	CbGbCtD
Bortezomib—CYP2C19—Probenecid—gout	0.0309	0.0496	CbGbCtD
Bortezomib—CYP2C19—Indomethacin—gout	0.0301	0.0483	CbGbCtD
Bortezomib—CYP2C9—Colchicine—gout	0.0287	0.0461	CbGbCtD
Bortezomib—CYP2C9—Probenecid—gout	0.0257	0.0412	CbGbCtD
Bortezomib—CYP2C9—Indomethacin—gout	0.025	0.0402	CbGbCtD
Bortezomib—CYP2C8—Hydrocortisone—gout	0.0221	0.0355	CbGbCtD
Bortezomib—CYP2C19—Prednisone—gout	0.0185	0.0296	CbGbCtD
Bortezomib—CYP3A4—Colchicine—gout	0.0167	0.0268	CbGbCtD
Bortezomib—CYP3A4—Probenecid—gout	0.015	0.024	CbGbCtD
Bortezomib—CYP3A4—Methylprednisolone—gout	0.0148	0.0237	CbGbCtD
Bortezomib—CYP3A4—Prednisolone—gout	0.00947	0.0152	CbGbCtD
Bortezomib—CYP3A4—Hydrocortisone—gout	0.00898	0.0144	CbGbCtD
Bortezomib—CYP3A4—Prednisone—gout	0.00894	0.0143	CbGbCtD
Bortezomib—Aspartame—SLC22A11—gout	0.00655	1	CrCbGaD
Bortezomib—SLC31A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A11—gout	0.00504	0.0766	CbGpPWpGaD
Bortezomib—SLC31A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—gout	0.00382	0.0581	CbGpPWpGaD
Bortezomib—PSMD2—Tolbutamide—Probenecid—gout	0.00375	0.549	CbGdCrCtD
Bortezomib—SLC31A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—gout	0.00355	0.054	CbGpPWpGaD
Bortezomib—SLC31A1—SLC-mediated transmembrane transport—SLC17A1—gout	0.00229	0.0348	CbGpPWpGaD
Bortezomib—SLC31A1—SLC-mediated transmembrane transport—SLC22A11—gout	0.00229	0.0348	CbGpPWpGaD
Bortezomib—PSMA1—Amino acid and derivative metabolism—BCKDHA—gout	0.00206	0.0313	CbGpPWpGaD
Bortezomib—PSMD1—Amino acid and derivative metabolism—BCKDHA—gout	0.00205	0.0312	CbGpPWpGaD
Bortezomib—PSMD2—Amino acid and derivative metabolism—BCKDHA—gout	0.00204	0.031	CbGpPWpGaD
Bortezomib—SLC31A1—SLC-mediated transmembrane transport—SLC22A12—gout	0.00173	0.0264	CbGpPWpGaD
Bortezomib—SLC31A1—SLC-mediated transmembrane transport—SLC2A9—gout	0.00161	0.0245	CbGpPWpGaD
Bortezomib—PSMB5—Amino acid and derivative metabolism—BCKDHA—gout	0.00156	0.0237	CbGpPWpGaD
Bortezomib—PSMB1—Amino acid and derivative metabolism—BCKDHA—gout	0.00156	0.0237	CbGpPWpGaD
Bortezomib—PSMB2—Amino acid and derivative metabolism—BCKDHA—gout	0.00156	0.0237	CbGpPWpGaD
Bortezomib—PSMB8—Amino acid and derivative metabolism—BCKDHA—gout	0.00154	0.0234	CbGpPWpGaD
Bortezomib—SLC31A1—Transmembrane transport of small molecules—SLC17A3—gout	0.00143	0.0217	CbGpPWpGaD
Bortezomib—CTSG—Peptide hormone metabolism—POMC—gout	0.00122	0.0186	CbGpPWpGaD
Bortezomib—PSMD1—Parkin-Ubiquitin Proteasomal System pathway—CASP1—gout	0.00119	0.0181	CbGpPWpGaD
Bortezomib—PSMD2—Parkin-Ubiquitin Proteasomal System pathway—CASP1—gout	0.00119	0.018	CbGpPWpGaD
Bortezomib—SLC31A1—Transmembrane transport of small molecules—SLC22A11—gout	0.00116	0.0177	CbGpPWpGaD
Bortezomib—SLC31A1—Transmembrane transport of small molecules—SLC17A1—gout	0.00116	0.0177	CbGpPWpGaD
Bortezomib—SLC31A1—Transmembrane transport of small molecules—SLC22A12—gout	0.000881	0.0134	CbGpPWpGaD
Bortezomib—SLC31A1—Transmembrane transport of small molecules—SLC2A9—gout	0.000819	0.0125	CbGpPWpGaD
Bortezomib—CYP3A4—Irinotecan Pathway—ABCG2—gout	0.000682	0.0104	CbGpPWpGaD
Bortezomib—SLC31A1—Transmembrane transport of small molecules—ABCG2—gout	0.00043	0.00655	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—BCKDHA—gout	0.000378	0.00575	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—BCKDHA—gout	0.000376	0.00572	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—BCKDHA—gout	0.000375	0.0057	CbGpPWpGaD
Bortezomib—PSMA1—Disease—PRPS1—gout	0.000368	0.0056	CbGpPWpGaD
Bortezomib—PSMA1—Disease—PRPS2—gout	0.000368	0.0056	CbGpPWpGaD
Bortezomib—PSMD1—Disease—PRPS1—gout	0.000366	0.00557	CbGpPWpGaD
Bortezomib—PSMD1—Disease—PRPS2—gout	0.000366	0.00557	CbGpPWpGaD
Bortezomib—PSMD2—Disease—PRPS2—gout	0.000365	0.00555	CbGpPWpGaD
Bortezomib—PSMD2—Disease—PRPS1—gout	0.000365	0.00555	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—PRPS1—gout	0.000308	0.00469	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—PRPS2—gout	0.000308	0.00469	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—HPRT1—gout	0.000308	0.00469	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—PRPS1—gout	0.000307	0.00467	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—HPRT1—gout	0.000307	0.00467	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—PRPS2—gout	0.000307	0.00467	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—HPRT1—gout	0.000305	0.00464	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—PRPS2—gout	0.000305	0.00464	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—PRPS1—gout	0.000305	0.00464	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—CASP1—gout	0.000295	0.00449	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—BCKDHA—gout	0.000287	0.00436	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—BCKDHA—gout	0.000287	0.00436	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—BCKDHA—gout	0.000287	0.00436	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—IL1RN—gout	0.000286	0.00435	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—BCKDHA—gout	0.000282	0.0043	CbGpPWpGaD
Bortezomib—PSMB1—Disease—PRPS1—gout	0.000279	0.00424	CbGpPWpGaD
Bortezomib—PSMB2—Disease—PRPS1—gout	0.000279	0.00424	CbGpPWpGaD
Bortezomib—PSMB5—Disease—PRPS2—gout	0.000279	0.00424	CbGpPWpGaD
Bortezomib—PSMB1—Disease—PRPS2—gout	0.000279	0.00424	CbGpPWpGaD
Bortezomib—PSMB2—Disease—PRPS2—gout	0.000279	0.00424	CbGpPWpGaD
Bortezomib—PSMB5—Disease—PRPS1—gout	0.000279	0.00424	CbGpPWpGaD
Bortezomib—PSMB8—Disease—PRPS1—gout	0.000275	0.00418	CbGpPWpGaD
Bortezomib—PSMB8—Disease—PRPS2—gout	0.000275	0.00418	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—NLRP3—gout	0.000264	0.00402	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—NLRP3—gout	0.000263	0.004	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—NLRP3—gout	0.000262	0.00398	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PRPS2—gout	0.000234	0.00355	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—HPRT1—gout	0.000234	0.00355	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—HPRT1—gout	0.000234	0.00355	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PRPS2—gout	0.000234	0.00355	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PRPS1—gout	0.000234	0.00355	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PRPS1—gout	0.000234	0.00355	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PRPS1—gout	0.000234	0.00355	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PRPS2—gout	0.000234	0.00355	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—HPRT1—gout	0.000234	0.00355	CbGpPWpGaD
Bortezomib—CTSG—Metabolism of proteins—POMC—gout	0.00023	0.00351	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—HPRT1—gout	0.00023	0.0035	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PRPS2—gout	0.00023	0.0035	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PRPS1—gout	0.00023	0.0035	CbGpPWpGaD
Bortezomib—PTGS1—Phase 1 - Functionalization of compounds—POMC—gout	0.000213	0.00324	CbGpPWpGaD
Bortezomib—PSMB8—Medrysone—Hydrocortisone—gout	0.000205	0.0301	CbGdCrCtD
Bortezomib—PSMB5—Immune System—NLRP3—gout	0.0002	0.00304	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—NLRP3—gout	0.0002	0.00304	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—NLRP3—gout	0.0002	0.00304	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—NLRP3—gout	0.000197	0.003	CbGpPWpGaD
Bortezomib—PSMD2—Fluticasone Propionate—Methylprednisolone—gout	0.000195	0.0285	CbGdCrCtD
Bortezomib—PSMB8—Medrysone—Methylprednisolone—gout	0.000194	0.0284	CbGdCrCtD
Bortezomib—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000185	0.00282	CbGpPWpGaD
Bortezomib—PSMB8—Medrysone—Prednisolone—gout	0.000173	0.0253	CbGdCrCtD
Bortezomib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—gout	0.00017	0.00258	CbGpPWpGaD
Bortezomib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000152	0.0023	CbGpPWpGaD
Bortezomib—CYP1A1—Phase 1 - Functionalization of compounds—POMC—gout	0.00015	0.00228	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—BCKDHA—gout	0.00015	0.00228	CbGpPWpGaD
Bortezomib—PSMB8—Fluorometholone—Hydrocortisone—gout	0.000149	0.0218	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Methylprednisolone—gout	0.00014	0.0206	CbGdCrCtD
Bortezomib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000139	0.00212	CbGpPWpGaD
Bortezomib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000138	0.0021	CbGpPWpGaD
Bortezomib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—gout	0.000138	0.00209	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CASP1—gout	0.000129	0.00196	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CASP1—gout	0.000128	0.00195	CbGpPWpGaD
Bortezomib—PSMB8—Fluorometholone—Prednisone—gout	0.000128	0.0188	CbGdCrCtD
Bortezomib—PSMD2—Immune System—CASP1—gout	0.000128	0.00194	CbGpPWpGaD
Bortezomib—PSMB8—Fluorometholone—Prednisolone—gout	0.000125	0.0183	CbGdCrCtD
Bortezomib—PSMA1—Immune System—IL1RN—gout	0.000125	0.0019	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IL1RN—gout	0.000124	0.00189	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL1RN—gout	0.000124	0.00188	CbGpPWpGaD
Bortezomib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—gout	0.000123	0.00187	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PRPS1—gout	0.000122	0.00186	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—HPRT1—gout	0.000122	0.00186	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PRPS2—gout	0.000122	0.00186	CbGpPWpGaD
Bortezomib—Body temperature increased—Naproxen—gout	0.000119	0.000401	CcSEcCtD
Bortezomib—Abdominal pain—Naproxen—gout	0.000119	0.000401	CcSEcCtD
Bortezomib—Nausea—Colchicine—gout	0.000119	0.000401	CcSEcCtD
Bortezomib—Osteoarthritis—Prednisone—gout	0.000118	0.000399	CcSEcCtD
Bortezomib—Gastrointestinal haemorrhage—Prednisone—gout	0.000118	0.000399	CcSEcCtD
Bortezomib—Diarrhoea—Allopurinol—gout	0.000118	0.000398	CcSEcCtD
Bortezomib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000118	0.0018	CbGpPWpGaD
Bortezomib—Weight increased—Methylprednisolone—gout	0.000118	0.000396	CcSEcCtD
Bortezomib—Psychotic disorder—Prednisone—gout	0.000116	0.000389	CcSEcCtD
Bortezomib—Infestation—Methylprednisolone—gout	0.000115	0.000388	CcSEcCtD
Bortezomib—Infestation NOS—Methylprednisolone—gout	0.000115	0.000388	CcSEcCtD
Bortezomib—Bradycardia—Prednisolone—gout	0.000115	0.000386	CcSEcCtD
Bortezomib—PSMB8—Testosterone Propionate—Hydrocortisone—gout	0.000114	0.0168	CbGdCrCtD
Bortezomib—Face oedema—Prednisone—gout	0.000114	0.000385	CcSEcCtD
Bortezomib—Dizziness—Allopurinol—gout	0.000114	0.000385	CcSEcCtD
Bortezomib—PSMA1—Metabolism—ABCG2—gout	0.000114	0.00174	CbGpPWpGaD
Bortezomib—Acute coronary syndrome—Methylprednisolone—gout	0.000114	0.000382	CcSEcCtD
Bortezomib—PSMD1—Metabolism—ABCG2—gout	0.000114	0.00173	CbGpPWpGaD
Bortezomib—Haemoglobin—Prednisolone—gout	0.000113	0.000381	CcSEcCtD
Bortezomib—PTGS1—Biological oxidations—POMC—gout	0.000113	0.00172	CbGpPWpGaD
Bortezomib—Nausea—Indomethacin—gout	0.000113	0.000381	CcSEcCtD
Bortezomib—Irritability—Prednisone—gout	0.000113	0.00038	CcSEcCtD
Bortezomib—PSMD2—Metabolism—ABCG2—gout	0.000113	0.00172	CbGpPWpGaD
Bortezomib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—gout	0.000113	0.00172	CbGpPWpGaD
Bortezomib—Neuropathy peripheral—Methylprednisolone—gout	0.000113	0.00038	CcSEcCtD
Bortezomib—Myocardial infarction—Methylprednisolone—gout	0.000113	0.00038	CcSEcCtD
Bortezomib—Haemorrhage—Prednisolone—gout	0.000113	0.00038	CcSEcCtD
Bortezomib—Cardiac arrest—Prednisone—gout	0.000113	0.000379	CcSEcCtD
Bortezomib—Bradycardia—Hydrocortisone—gout	0.000112	0.000377	CcSEcCtD
Bortezomib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—gout	0.000112	0.0017	CbGpPWpGaD
Bortezomib—Hypersensitivity—Naproxen—gout	0.000111	0.000374	CcSEcCtD
Bortezomib—Haemoglobin—Hydrocortisone—gout	0.000111	0.000373	CcSEcCtD
Bortezomib—Haemorrhage—Hydrocortisone—gout	0.00011	0.000371	CcSEcCtD
Bortezomib—Vomiting—Allopurinol—gout	0.00011	0.00037	CcSEcCtD
Bortezomib—Hallucination—Hydrocortisone—gout	0.00011	0.000369	CcSEcCtD
Bortezomib—Rash—Allopurinol—gout	0.000109	0.000367	CcSEcCtD
Bortezomib—Dermatitis—Allopurinol—gout	0.000109	0.000366	CcSEcCtD
Bortezomib—Visual impairment—Prednisolone—gout	0.000109	0.000366	CcSEcCtD
Bortezomib—Dry skin—Prednisone—gout	0.000109	0.000365	CcSEcCtD
Bortezomib—Headache—Allopurinol—gout	0.000108	0.000364	CcSEcCtD
Bortezomib—Asthenia—Naproxen—gout	0.000108	0.000364	CcSEcCtD
Bortezomib—Connective tissue disorder—Hydrocortisone—gout	0.000108	0.000364	CcSEcCtD
Bortezomib—Hypokalaemia—Prednisone—gout	0.000108	0.000363	CcSEcCtD
Bortezomib—PSMB8—Diflorasone—Methylprednisolone—gout	0.000107	0.0157	CbGdCrCtD
Bortezomib—Pruritus—Naproxen—gout	0.000107	0.000359	CcSEcCtD
Bortezomib—CYP1A1—Metabolism—BCKDHA—gout	0.000106	0.00161	CbGpPWpGaD
Bortezomib—Bradycardia—Methylprednisolone—gout	0.000105	0.000355	CcSEcCtD
Bortezomib—PSMD2—Betamethasone—Hydrocortisone—gout	0.000105	0.0153	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Hydrocortisone—gout	0.000105	0.0153	CbGdCrCtD
Bortezomib—Muscular weakness—Prednisone—gout	0.000104	0.000352	CcSEcCtD
Bortezomib—Haemoglobin—Methylprednisolone—gout	0.000104	0.00035	CcSEcCtD
Bortezomib—Haemorrhage—Methylprednisolone—gout	0.000103	0.000348	CcSEcCtD
Bortezomib—Diarrhoea—Naproxen—gout	0.000103	0.000347	CcSEcCtD
Bortezomib—Abdominal distension—Prednisone—gout	0.000103	0.000347	CcSEcCtD
Bortezomib—Hallucination—Methylprednisolone—gout	0.000103	0.000346	CcSEcCtD
Bortezomib—Eye disorder—Hydrocortisone—gout	0.000103	0.000346	CcSEcCtD
Bortezomib—Nausea—Allopurinol—gout	0.000103	0.000345	CcSEcCtD
Bortezomib—Connective tissue disorder—Methylprednisolone—gout	0.000102	0.000342	CcSEcCtD
Bortezomib—Arrhythmia—Prednisolone—gout	0.000101	0.000339	CcSEcCtD
Bortezomib—Pancreatitis—Prednisone—gout	0.0001	0.000338	CcSEcCtD
Bortezomib—Dizziness—Naproxen—gout	9.97e-05	0.000336	CcSEcCtD
Bortezomib—Visual impairment—Methylprednisolone—gout	9.97e-05	0.000336	CcSEcCtD
Bortezomib—Immune system disorder—Hydrocortisone—gout	9.94e-05	0.000335	CcSEcCtD
Bortezomib—PSMD2—Betamethasone—Methylprednisolone—gout	9.88e-05	0.0145	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Methylprednisolone—gout	9.88e-05	0.0145	CbGdCrCtD
Bortezomib—Arrhythmia—Hydrocortisone—gout	9.84e-05	0.000331	CcSEcCtD
Bortezomib—Erythema—Prednisolone—gout	9.81e-05	0.00033	CcSEcCtD
Bortezomib—PSMB5—Immune System—CASP1—gout	9.77e-05	0.00149	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CASP1—gout	9.77e-05	0.00149	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CASP1—gout	9.77e-05	0.00149	CbGpPWpGaD
Bortezomib—PSMB8—Diflorasone—Prednisone—gout	9.76e-05	0.0143	CbGdCrCtD
Bortezomib—CYP2C8—Metabolism—BCKDHA—gout	9.68e-05	0.00147	CbGpPWpGaD
Bortezomib—Eye disorder—Methylprednisolone—gout	9.67e-05	0.000325	CcSEcCtD
Bortezomib—Mental disorder—Hydrocortisone—gout	9.65e-05	0.000325	CcSEcCtD
Bortezomib—PSMB8—Immune System—CASP1—gout	9.63e-05	0.00147	CbGpPWpGaD
Bortezomib—Cardiac disorder—Methylprednisolone—gout	9.6e-05	0.000323	CcSEcCtD
Bortezomib—Vomiting—Naproxen—gout	9.59e-05	0.000323	CcSEcCtD
Bortezomib—Malnutrition—Hydrocortisone—gout	9.58e-05	0.000323	CcSEcCtD
Bortezomib—Erythema—Hydrocortisone—gout	9.58e-05	0.000323	CcSEcCtD
Bortezomib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—gout	9.57e-05	0.00146	CbGpPWpGaD
Bortezomib—Neutropenia—Prednisone—gout	9.57e-05	0.000322	CcSEcCtD
Bortezomib—PSMB8—Diflorasone—Prednisolone—gout	9.52e-05	0.0139	CbGdCrCtD
Bortezomib—Rash—Naproxen—gout	9.51e-05	0.00032	CcSEcCtD
Bortezomib—Dermatitis—Naproxen—gout	9.5e-05	0.00032	CcSEcCtD
Bortezomib—PSMB2—Immune System—IL1RN—gout	9.46e-05	0.00144	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL1RN—gout	9.46e-05	0.00144	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL1RN—gout	9.46e-05	0.00144	CbGpPWpGaD
Bortezomib—Headache—Naproxen—gout	9.45e-05	0.000318	CcSEcCtD
Bortezomib—Erectile dysfunction—Prednisone—gout	9.43e-05	0.000317	CcSEcCtD
Bortezomib—Angiopathy—Methylprednisolone—gout	9.38e-05	0.000316	CcSEcCtD
Bortezomib—Immune system disorder—Methylprednisolone—gout	9.34e-05	0.000315	CcSEcCtD
Bortezomib—PSMB8—Immune System—IL1RN—gout	9.33e-05	0.00142	CbGpPWpGaD
Bortezomib—Mediastinal disorder—Methylprednisolone—gout	9.32e-05	0.000314	CcSEcCtD
Bortezomib—Weight increased—Prednisone—gout	9.31e-05	0.000314	CcSEcCtD
Bortezomib—Weight decreased—Prednisone—gout	9.26e-05	0.000312	CcSEcCtD
Bortezomib—Vision blurred—Prednisolone—gout	9.25e-05	0.000311	CcSEcCtD
Bortezomib—Arrhythmia—Methylprednisolone—gout	9.24e-05	0.000311	CcSEcCtD
Bortezomib—Hyperglycaemia—Prednisone—gout	9.23e-05	0.000311	CcSEcCtD
Bortezomib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—gout	9.11e-05	0.00139	CbGpPWpGaD
Bortezomib—Ill-defined disorder—Prednisolone—gout	9.1e-05	0.000307	CcSEcCtD
Bortezomib—Mental disorder—Methylprednisolone—gout	9.06e-05	0.000305	CcSEcCtD
Bortezomib—PSMD2—Dexamethasone—Prednisone—gout	9.02e-05	0.0132	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Prednisone—gout	9.02e-05	0.0132	CbGdCrCtD
Bortezomib—Erythema—Methylprednisolone—gout	9e-05	0.000303	CcSEcCtD
Bortezomib—Malnutrition—Methylprednisolone—gout	9e-05	0.000303	CcSEcCtD
Bortezomib—Acute coronary syndrome—Prednisone—gout	9e-05	0.000303	CcSEcCtD
Bortezomib—Angioedema—Prednisolone—gout	8.97e-05	0.000302	CcSEcCtD
Bortezomib—Nausea—Naproxen—gout	8.96e-05	0.000302	CcSEcCtD
Bortezomib—Myocardial infarction—Prednisone—gout	8.94e-05	0.000301	CcSEcCtD
Bortezomib—Neuropathy peripheral—Prednisone—gout	8.94e-05	0.000301	CcSEcCtD
Bortezomib—Ill-defined disorder—Hydrocortisone—gout	8.89e-05	0.000299	CcSEcCtD
Bortezomib—Malaise—Prednisolone—gout	8.85e-05	0.000298	CcSEcCtD
Bortezomib—Vertigo—Prednisolone—gout	8.82e-05	0.000297	CcSEcCtD
Bortezomib—PSMD2—Betamethasone—Prednisolone—gout	8.8e-05	0.0129	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Prednisolone—gout	8.8e-05	0.0129	CbGdCrCtD
Bortezomib—Syncope—Prednisolone—gout	8.8e-05	0.000296	CcSEcCtD
Bortezomib—Angioedema—Hydrocortisone—gout	8.76e-05	0.000295	CcSEcCtD
Bortezomib—PSMB5—Metabolism—ABCG2—gout	8.65e-05	0.00132	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—ABCG2—gout	8.65e-05	0.00132	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—ABCG2—gout	8.65e-05	0.00132	CbGpPWpGaD
Bortezomib—Malaise—Hydrocortisone—gout	8.64e-05	0.000291	CcSEcCtD
Bortezomib—CYP2C19—Metabolism—BCKDHA—gout	8.64e-05	0.00131	CbGpPWpGaD
Bortezomib—Loss of consciousness—Prednisolone—gout	8.62e-05	0.00029	CcSEcCtD
Bortezomib—Vertigo—Hydrocortisone—gout	8.61e-05	0.00029	CcSEcCtD
Bortezomib—CYP1A1—Metabolism—HPRT1—gout	8.6e-05	0.00131	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PRPS2—gout	8.6e-05	0.00131	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PRPS1—gout	8.6e-05	0.00131	CbGpPWpGaD
Bortezomib—Syncope—Hydrocortisone—gout	8.59e-05	0.000289	CcSEcCtD
Bortezomib—PSMB8—Norethindrone—Hydrocortisone—gout	8.58e-05	0.0126	CbGdCrCtD
Bortezomib—PSMB8—Metabolism—ABCG2—gout	8.52e-05	0.0013	CbGpPWpGaD
Bortezomib—Convulsion—Prednisolone—gout	8.5e-05	0.000286	CcSEcCtD
Bortezomib—Hypertension—Prednisolone—gout	8.47e-05	0.000285	CcSEcCtD
Bortezomib—Loss of consciousness—Hydrocortisone—gout	8.42e-05	0.000284	CcSEcCtD
Bortezomib—Ill-defined disorder—Methylprednisolone—gout	8.35e-05	0.000281	CcSEcCtD
Bortezomib—Bradycardia—Prednisone—gout	8.34e-05	0.000281	CcSEcCtD
Bortezomib—Convulsion—Hydrocortisone—gout	8.3e-05	0.00028	CcSEcCtD
Bortezomib—Hypertension—Hydrocortisone—gout	8.27e-05	0.000279	CcSEcCtD
Bortezomib—Discomfort—Prednisolone—gout	8.25e-05	0.000278	CcSEcCtD
Bortezomib—Haemoglobin—Prednisone—gout	8.23e-05	0.000277	CcSEcCtD
Bortezomib—Angioedema—Methylprednisolone—gout	8.23e-05	0.000277	CcSEcCtD
Bortezomib—Haemorrhage—Prednisone—gout	8.19e-05	0.000276	CcSEcCtD
Bortezomib—Myalgia—Hydrocortisone—gout	8.16e-05	0.000275	CcSEcCtD
Bortezomib—Hallucination—Prednisone—gout	8.15e-05	0.000274	CcSEcCtD
Bortezomib—Anxiety—Hydrocortisone—gout	8.13e-05	0.000274	CcSEcCtD
Bortezomib—Malaise—Methylprednisolone—gout	8.12e-05	0.000273	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	8.1e-05	0.000273	CcSEcCtD
Bortezomib—Vertigo—Methylprednisolone—gout	8.09e-05	0.000272	CcSEcCtD
Bortezomib—Syncope—Methylprednisolone—gout	8.07e-05	0.000272	CcSEcCtD
Bortezomib—Discomfort—Hydrocortisone—gout	8.06e-05	0.000271	CcSEcCtD
Bortezomib—Connective tissue disorder—Prednisone—gout	8.05e-05	0.000271	CcSEcCtD
Bortezomib—Oedema—Prednisolone—gout	8.01e-05	0.00027	CcSEcCtD
Bortezomib—Anaphylactic shock—Prednisolone—gout	8.01e-05	0.00027	CcSEcCtD
Bortezomib—CYP1A1—Biological oxidations—POMC—gout	7.97e-05	0.00121	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—BCKDHA—gout	7.94e-05	0.00121	CbGpPWpGaD
Bortezomib—Loss of consciousness—Methylprednisolone—gout	7.91e-05	0.000266	CcSEcCtD
Bortezomib—CYP2C8—Metabolism—HPRT1—gout	7.89e-05	0.0012	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PRPS2—gout	7.89e-05	0.0012	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PRPS1—gout	7.89e-05	0.0012	CbGpPWpGaD
Bortezomib—Shock—Prednisolone—gout	7.88e-05	0.000265	CcSEcCtD
Bortezomib—CYP2C9—Metabolism—BCKDHA—gout	7.88e-05	0.0012	CbGpPWpGaD
Bortezomib—Anaphylactic shock—Hydrocortisone—gout	7.82e-05	0.000263	CcSEcCtD
Bortezomib—Oedema—Hydrocortisone—gout	7.82e-05	0.000263	CcSEcCtD
Bortezomib—Tachycardia—Prednisolone—gout	7.82e-05	0.000263	CcSEcCtD
Bortezomib—Convulsion—Methylprednisolone—gout	7.8e-05	0.000263	CcSEcCtD
Bortezomib—Hypertension—Methylprednisolone—gout	7.77e-05	0.000262	CcSEcCtD
Bortezomib—Infection—Hydrocortisone—gout	7.77e-05	0.000262	CcSEcCtD
Bortezomib—Hyperhidrosis—Prednisolone—gout	7.74e-05	0.000261	CcSEcCtD
Bortezomib—Shock—Hydrocortisone—gout	7.7e-05	0.000259	CcSEcCtD
Bortezomib—Nervous system disorder—Hydrocortisone—gout	7.67e-05	0.000258	CcSEcCtD
Bortezomib—Arthralgia—Methylprednisolone—gout	7.67e-05	0.000258	CcSEcCtD
Bortezomib—Myalgia—Methylprednisolone—gout	7.67e-05	0.000258	CcSEcCtD
Bortezomib—Eye disorder—Prednisone—gout	7.66e-05	0.000258	CcSEcCtD
Bortezomib—Anxiety—Methylprednisolone—gout	7.64e-05	0.000257	CcSEcCtD
Bortezomib—Tachycardia—Hydrocortisone—gout	7.63e-05	0.000257	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	7.61e-05	0.000256	CcSEcCtD
Bortezomib—Flushing—Prednisone—gout	7.6e-05	0.000256	CcSEcCtD
Bortezomib—Skin disorder—Hydrocortisone—gout	7.6e-05	0.000256	CcSEcCtD
Bortezomib—Discomfort—Methylprednisolone—gout	7.57e-05	0.000255	CcSEcCtD
Bortezomib—Hyperhidrosis—Hydrocortisone—gout	7.56e-05	0.000255	CcSEcCtD
Bortezomib—Anorexia—Hydrocortisone—gout	7.46e-05	0.000251	CcSEcCtD
Bortezomib—Angiopathy—Prednisone—gout	7.43e-05	0.00025	CcSEcCtD
Bortezomib—Confusional state—Methylprednisolone—gout	7.41e-05	0.000249	CcSEcCtD
Bortezomib—Immune system disorder—Prednisone—gout	7.4e-05	0.000249	CcSEcCtD
Bortezomib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—gout	7.39e-05	0.00112	CbGpPWpGaD
Bortezomib—Anaphylactic shock—Methylprednisolone—gout	7.35e-05	0.000247	CcSEcCtD
Bortezomib—Arrhythmia—Prednisone—gout	7.32e-05	0.000246	CcSEcCtD
Bortezomib—CYP2C8—Biological oxidations—POMC—gout	7.31e-05	0.00111	CbGpPWpGaD
Bortezomib—Hypotension—Hydrocortisone—gout	7.31e-05	0.000246	CcSEcCtD
Bortezomib—Infection—Methylprednisolone—gout	7.3e-05	0.000246	CcSEcCtD
Bortezomib—Insomnia—Prednisolone—gout	7.24e-05	0.000244	CcSEcCtD
Bortezomib—Shock—Methylprednisolone—gout	7.23e-05	0.000243	CcSEcCtD
Bortezomib—Nervous system disorder—Methylprednisolone—gout	7.21e-05	0.000243	CcSEcCtD
Bortezomib—Paraesthesia—Prednisolone—gout	7.19e-05	0.000242	CcSEcCtD
Bortezomib—Mental disorder—Prednisone—gout	7.18e-05	0.000242	CcSEcCtD
Bortezomib—Tachycardia—Methylprednisolone—gout	7.17e-05	0.000241	CcSEcCtD
Bortezomib—Skin disorder—Methylprednisolone—gout	7.14e-05	0.00024	CcSEcCtD
Bortezomib—Erythema—Prednisone—gout	7.13e-05	0.00024	CcSEcCtD
Bortezomib—Malnutrition—Prednisone—gout	7.13e-05	0.00024	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Hydrocortisone—gout	7.13e-05	0.00024	CcSEcCtD
Bortezomib—Hyperhidrosis—Methylprednisolone—gout	7.1e-05	0.000239	CcSEcCtD
Bortezomib—Insomnia—Hydrocortisone—gout	7.07e-05	0.000238	CcSEcCtD
Bortezomib—CYP2C19—Metabolism—PRPS1—gout	7.04e-05	0.00107	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—HPRT1—gout	7.04e-05	0.00107	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PRPS2—gout	7.04e-05	0.00107	CbGpPWpGaD
Bortezomib—Paraesthesia—Hydrocortisone—gout	7.02e-05	0.000236	CcSEcCtD
Bortezomib—Dyspepsia—Hydrocortisone—gout	6.89e-05	0.000232	CcSEcCtD
Bortezomib—Hypotension—Methylprednisolone—gout	6.87e-05	0.000231	CcSEcCtD
Bortezomib—Pain—Prednisolone—gout	6.85e-05	0.000231	CcSEcCtD
Bortezomib—PSMB8—Levonorgestrel—Hydrocortisone—gout	6.83e-05	0.00999	CbGdCrCtD
Bortezomib—Decreased appetite—Hydrocortisone—gout	6.8e-05	0.000229	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Hydrocortisone—gout	6.75e-05	0.000227	CcSEcCtD
Bortezomib—Fatigue—Hydrocortisone—gout	6.74e-05	0.000227	CcSEcCtD
Bortezomib—CYP1A2—Metabolism—BCKDHA—gout	6.73e-05	0.00102	CbGpPWpGaD
Bortezomib—Vision blurred—Prednisone—gout	6.72e-05	0.000226	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Methylprednisolone—gout	6.7e-05	0.000225	CcSEcCtD
Bortezomib—Pain—Hydrocortisone—gout	6.69e-05	0.000225	CcSEcCtD
Bortezomib—Insomnia—Methylprednisolone—gout	6.65e-05	0.000224	CcSEcCtD
Bortezomib—Ill-defined disorder—Prednisone—gout	6.62e-05	0.000223	CcSEcCtD
Bortezomib—Feeling abnormal—Prednisolone—gout	6.6e-05	0.000222	CcSEcCtD
Bortezomib—Paraesthesia—Methylprednisolone—gout	6.6e-05	0.000222	CcSEcCtD
Bortezomib—Anaemia—Prednisone—gout	6.59e-05	0.000222	CcSEcCtD
Bortezomib—Agitation—Prednisone—gout	6.55e-05	0.000221	CcSEcCtD
Bortezomib—CYP2C19—Biological oxidations—POMC—gout	6.52e-05	0.000993	CbGpPWpGaD
Bortezomib—Angioedema—Prednisone—gout	6.52e-05	0.000219	CcSEcCtD
Bortezomib—CYP2D6—Metabolism—PRPS1—gout	6.48e-05	0.000985	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—HPRT1—gout	6.48e-05	0.000985	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PRPS2—gout	6.48e-05	0.000985	CbGpPWpGaD
Bortezomib—Dyspepsia—Methylprednisolone—gout	6.47e-05	0.000218	CcSEcCtD
Bortezomib—Feeling abnormal—Hydrocortisone—gout	6.45e-05	0.000217	CcSEcCtD
Bortezomib—Malaise—Prednisone—gout	6.43e-05	0.000216	CcSEcCtD
Bortezomib—CYP2C9—Metabolism—HPRT1—gout	6.42e-05	0.000977	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PRPS1—gout	6.42e-05	0.000977	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PRPS2—gout	6.42e-05	0.000977	CbGpPWpGaD
Bortezomib—Vertigo—Prednisone—gout	6.41e-05	0.000216	CcSEcCtD
Bortezomib—Gastrointestinal pain—Hydrocortisone—gout	6.4e-05	0.000215	CcSEcCtD
Bortezomib—Syncope—Prednisone—gout	6.39e-05	0.000215	CcSEcCtD
Bortezomib—Urticaria—Prednisolone—gout	6.36e-05	0.000214	CcSEcCtD
Bortezomib—Fatigue—Methylprednisolone—gout	6.34e-05	0.000213	CcSEcCtD
Bortezomib—Loss of consciousness—Prednisone—gout	6.27e-05	0.000211	CcSEcCtD
Bortezomib—Urticaria—Hydrocortisone—gout	6.21e-05	0.000209	CcSEcCtD
Bortezomib—Abdominal pain—Hydrocortisone—gout	6.18e-05	0.000208	CcSEcCtD
Bortezomib—Body temperature increased—Hydrocortisone—gout	6.18e-05	0.000208	CcSEcCtD
Bortezomib—Convulsion—Prednisone—gout	6.18e-05	0.000208	CcSEcCtD
Bortezomib—Hypertension—Prednisone—gout	6.16e-05	0.000207	CcSEcCtD
Bortezomib—PSMB8—Dexamethasone—Hydrocortisone—gout	6.08e-05	0.0089	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Hydrocortisone—gout	6.08e-05	0.0089	CbGdCrCtD
Bortezomib—Arthralgia—Prednisone—gout	6.07e-05	0.000204	CcSEcCtD
Bortezomib—Myalgia—Prednisone—gout	6.07e-05	0.000204	CcSEcCtD
Bortezomib—Feeling abnormal—Methylprednisolone—gout	6.06e-05	0.000204	CcSEcCtD
Bortezomib—Anxiety—Prednisone—gout	6.05e-05	0.000204	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	6.03e-05	0.000203	CcSEcCtD
Bortezomib—Gastrointestinal pain—Methylprednisolone—gout	6.01e-05	0.000202	CcSEcCtD
Bortezomib—CYP2D6—Biological oxidations—POMC—gout	6e-05	0.000913	CbGpPWpGaD
Bortezomib—Discomfort—Prednisone—gout	6e-05	0.000202	CcSEcCtD
Bortezomib—CYP2C9—Biological oxidations—POMC—gout	5.95e-05	0.000905	CbGpPWpGaD
Bortezomib—Hypersensitivity—Prednisolone—gout	5.9e-05	0.000199	CcSEcCtD
Bortezomib—Urticaria—Methylprednisolone—gout	5.84e-05	0.000197	CcSEcCtD
Bortezomib—Oedema—Prednisone—gout	5.82e-05	0.000196	CcSEcCtD
Bortezomib—Anaphylactic shock—Prednisone—gout	5.82e-05	0.000196	CcSEcCtD
Bortezomib—Abdominal pain—Methylprednisolone—gout	5.81e-05	0.000196	CcSEcCtD
Bortezomib—Infection—Prednisone—gout	5.78e-05	0.000195	CcSEcCtD
Bortezomib—Hypersensitivity—Hydrocortisone—gout	5.76e-05	0.000194	CcSEcCtD
Bortezomib—PSMB8—Dexamethasone—Methylprednisolone—gout	5.73e-05	0.00839	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Methylprednisolone—gout	5.73e-05	0.00839	CbGdCrCtD
Bortezomib—Shock—Prednisone—gout	5.73e-05	0.000193	CcSEcCtD
Bortezomib—Nervous system disorder—Prednisone—gout	5.71e-05	0.000192	CcSEcCtD
Bortezomib—Tachycardia—Prednisone—gout	5.68e-05	0.000191	CcSEcCtD
Bortezomib—Skin disorder—Prednisone—gout	5.65e-05	0.00019	CcSEcCtD
Bortezomib—Hyperhidrosis—Prednisone—gout	5.63e-05	0.000189	CcSEcCtD
Bortezomib—Asthenia—Hydrocortisone—gout	5.61e-05	0.000189	CcSEcCtD
Bortezomib—Anorexia—Prednisone—gout	5.55e-05	0.000187	CcSEcCtD
Bortezomib—Pruritus—Hydrocortisone—gout	5.53e-05	0.000186	CcSEcCtD
Bortezomib—CYP1A2—Metabolism—PRPS2—gout	5.49e-05	0.000834	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—HPRT1—gout	5.49e-05	0.000834	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PRPS1—gout	5.49e-05	0.000834	CbGpPWpGaD
Bortezomib—Hypersensitivity—Methylprednisolone—gout	5.41e-05	0.000182	CcSEcCtD
Bortezomib—Diarrhoea—Hydrocortisone—gout	5.35e-05	0.00018	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Prednisone—gout	5.3e-05	0.000179	CcSEcCtD
Bortezomib—Dizziness—Prednisolone—gout	5.3e-05	0.000178	CcSEcCtD
Bortezomib—Asthenia—Methylprednisolone—gout	5.27e-05	0.000178	CcSEcCtD
Bortezomib—Insomnia—Prednisone—gout	5.26e-05	0.000177	CcSEcCtD
Bortezomib—PSMB8—Betamethasone—Prednisone—gout	5.23e-05	0.00766	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Prednisone—gout	5.23e-05	0.00766	CbGdCrCtD
Bortezomib—Paraesthesia—Prednisone—gout	5.23e-05	0.000176	CcSEcCtD
Bortezomib—Pruritus—Methylprednisolone—gout	5.2e-05	0.000175	CcSEcCtD
Bortezomib—CYP3A4—Metabolism—BCKDHA—gout	5.19e-05	0.00079	CbGpPWpGaD
Bortezomib—Dizziness—Hydrocortisone—gout	5.17e-05	0.000174	CcSEcCtD
Bortezomib—Dyspepsia—Prednisone—gout	5.12e-05	0.000172	CcSEcCtD
Bortezomib—PSMB8—Betamethasone—Prednisolone—gout	5.11e-05	0.00748	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Prednisolone—gout	5.11e-05	0.00748	CbGdCrCtD
Bortezomib—CYP1A2—Biological oxidations—POMC—gout	5.08e-05	0.000773	CbGpPWpGaD
Bortezomib—Decreased appetite—Prednisone—gout	5.06e-05	0.00017	CcSEcCtD
Bortezomib—Rash—Prednisolone—gout	5.05e-05	0.00017	CcSEcCtD
Bortezomib—Dermatitis—Prednisolone—gout	5.05e-05	0.00017	CcSEcCtD
Bortezomib—Diarrhoea—Methylprednisolone—gout	5.03e-05	0.000169	CcSEcCtD
Bortezomib—Fatigue—Prednisone—gout	5.02e-05	0.000169	CcSEcCtD
Bortezomib—Headache—Prednisolone—gout	5.02e-05	0.000169	CcSEcCtD
Bortezomib—Constipation—Prednisone—gout	4.98e-05	0.000168	CcSEcCtD
Bortezomib—Vomiting—Hydrocortisone—gout	4.97e-05	0.000167	CcSEcCtD
Bortezomib—Rash—Hydrocortisone—gout	4.93e-05	0.000166	CcSEcCtD
Bortezomib—Dermatitis—Hydrocortisone—gout	4.93e-05	0.000166	CcSEcCtD
Bortezomib—Headache—Hydrocortisone—gout	4.9e-05	0.000165	CcSEcCtD
Bortezomib—PSMA1—Metabolism—POMC—gout	4.88e-05	0.000743	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—POMC—gout	4.86e-05	0.00074	CbGpPWpGaD
Bortezomib—Dizziness—Methylprednisolone—gout	4.86e-05	0.000164	CcSEcCtD
Bortezomib—PSMD2—Metabolism—POMC—gout	4.84e-05	0.000736	CbGpPWpGaD
Bortezomib—Feeling abnormal—Prednisone—gout	4.8e-05	0.000161	CcSEcCtD
Bortezomib—Gastrointestinal pain—Prednisone—gout	4.76e-05	0.00016	CcSEcCtD
Bortezomib—Nausea—Prednisolone—gout	4.76e-05	0.00016	CcSEcCtD
Bortezomib—Vomiting—Methylprednisolone—gout	4.67e-05	0.000157	CcSEcCtD
Bortezomib—Nausea—Hydrocortisone—gout	4.65e-05	0.000156	CcSEcCtD
Bortezomib—Rash—Methylprednisolone—gout	4.63e-05	0.000156	CcSEcCtD
Bortezomib—Dermatitis—Methylprednisolone—gout	4.63e-05	0.000156	CcSEcCtD
Bortezomib—Urticaria—Prednisone—gout	4.62e-05	0.000156	CcSEcCtD
Bortezomib—Headache—Methylprednisolone—gout	4.6e-05	0.000155	CcSEcCtD
Bortezomib—Body temperature increased—Prednisone—gout	4.6e-05	0.000155	CcSEcCtD
Bortezomib—Abdominal pain—Prednisone—gout	4.6e-05	0.000155	CcSEcCtD
Bortezomib—PTGS1—Metabolism—ABCG2—gout	4.52e-05	0.000688	CbGpPWpGaD
Bortezomib—Nausea—Methylprednisolone—gout	4.36e-05	0.000147	CcSEcCtD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—POMC—gout	4.35e-05	0.000661	CbGpPWpGaD
Bortezomib—Hypersensitivity—Prednisone—gout	4.29e-05	0.000144	CcSEcCtD
Bortezomib—CYP3A4—Metabolism—HPRT1—gout	4.23e-05	0.000644	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PRPS2—gout	4.23e-05	0.000644	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PRPS1—gout	4.23e-05	0.000644	CbGpPWpGaD
Bortezomib—Asthenia—Prednisone—gout	4.18e-05	0.000141	CcSEcCtD
Bortezomib—Pruritus—Prednisone—gout	4.12e-05	0.000139	CcSEcCtD
Bortezomib—PSMA1—Signaling Pathways—POMC—gout	4.08e-05	0.000621	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—POMC—gout	4.07e-05	0.000618	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—POMC—gout	4.05e-05	0.000615	CbGpPWpGaD
Bortezomib—Diarrhoea—Prednisone—gout	3.98e-05	0.000134	CcSEcCtD
Bortezomib—CYP3A4—Biological oxidations—POMC—gout	3.92e-05	0.000597	CbGpPWpGaD
Bortezomib—Dizziness—Prednisone—gout	3.85e-05	0.00013	CcSEcCtD
Bortezomib—PSMB5—Metabolism—POMC—gout	3.7e-05	0.000563	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—POMC—gout	3.7e-05	0.000563	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—POMC—gout	3.7e-05	0.000563	CbGpPWpGaD
Bortezomib—Vomiting—Prednisone—gout	3.7e-05	0.000125	CcSEcCtD
Bortezomib—Rash—Prednisone—gout	3.67e-05	0.000124	CcSEcCtD
Bortezomib—Dermatitis—Prednisone—gout	3.67e-05	0.000123	CcSEcCtD
Bortezomib—PSMB8—Metabolism—POMC—gout	3.65e-05	0.000555	CbGpPWpGaD
Bortezomib—Headache—Prednisone—gout	3.65e-05	0.000123	CcSEcCtD
Bortezomib—Nausea—Prednisone—gout	3.46e-05	0.000116	CcSEcCtD
Bortezomib—CYP1A1—Metabolism—ABCG2—gout	3.18e-05	0.000484	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—POMC—gout	3.1e-05	0.000471	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—POMC—gout	3.1e-05	0.000471	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—POMC—gout	3.1e-05	0.000471	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—gout	3.06e-05	0.000466	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—POMC—gout	3.05e-05	0.000464	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ABCG2—gout	2.92e-05	0.000444	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—gout	2.81e-05	0.000427	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ABCG2—gout	2.61e-05	0.000396	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—gout	2.51e-05	0.000381	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ABCG2—gout	2.4e-05	0.000365	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ABCG2—gout	2.38e-05	0.000361	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—gout	2.28e-05	0.000348	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ABCG2—gout	2.03e-05	0.000309	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—gout	1.95e-05	0.000297	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—POMC—gout	1.94e-05	0.000294	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ABCG2—gout	1.57e-05	0.000238	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—POMC—gout	1.36e-05	0.000207	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—POMC—gout	1.25e-05	0.00019	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—POMC—gout	1.12e-05	0.00017	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—POMC—gout	1.03e-05	0.000156	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—POMC—gout	1.02e-05	0.000155	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—POMC—gout	8.69e-06	0.000132	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—POMC—gout	6.71e-06	0.000102	CbGpPWpGaD
